These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10027666)

  • 1. Gastro-oesophageal reflux symptoms--clinical findings and effect of ranitidine treatment.
    Hallerbäck B; Glise H; Johansson B; Rosseland AR; Hultén S; Carling L; Knapstad LJ
    Eur J Surg Suppl; 1998; (583):6-13. PubMed ID: 10027666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cisapride and ranitidine in the treatment of gastro-oesophageal reflux disease--a comparative randomized double-blind trial.
    Arvanitakis C; Nikopoułos A; Theoharidis A; Giannoulis E; Vagios I; Anthopoulou H; Michailidis D; Tourkantonis A
    Aliment Pharmacol Ther; 1993 Dec; 7(6):635-41. PubMed ID: 8161670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On-demand treatment of gastro-oesophageal reflux symptoms: a comparison of ranitidine 75 mg with cimetidine 200 mg or placebo.
    Galmiche JP; Shi G; Simon B; Casset-Semanza F; Slama A
    Aliment Pharmacol Ther; 1998 Sep; 12(9):909-17. PubMed ID: 9768535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of pantoprazole versus ranitidine in the treatment of patients with symptomatic gastroesophageal reflux disease.
    van Zyl J; van Rensburg C; Vieweg W; Fischer R
    Digestion; 2004; 70(1):61-9. PubMed ID: 15297779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of life during acute and intermittent treatment of gastro-oesophageal reflux disease with omeprazole compared with ranitidine. Results from a multicentre clinical trial. The European Study Group.
    Wiklund I; Bardhan KD; Müller-Lissner S; Bigard MA; Bianchi Porro G; Ponce J; Hosie J; Scott M; Weir D; Fulton C; Gillon K; Peacock R
    Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):19-27. PubMed ID: 9615259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lansoprazole compared with ranitidine for the treatment of nonerosive gastroesophageal reflux disease.
    Richter JE; Campbell DR; Kahrilas PJ; Huang B; Fludas C
    Arch Intern Med; 2000 Jun; 160(12):1803-9. PubMed ID: 10871974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Symptomatic gastro-oesophageal reflux disease: double blind controlled study of intermittent treatment with omeprazole or ranitidine. The European Study Group.
    Bardhan KD; Müller-Lissner S; Bigard MA; Bianchi Porro G; Ponce J; Hosie J; Scott M; Weir DG; Gillon KR; Peacock RA; Fulton C
    BMJ; 1999 Feb; 318(7182):502-7. PubMed ID: 10024259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omeprazole 10 milligrams once daily, omeprazole 20 milligrams once daily, or ranitidine 150 milligrams twice daily, evaluated as initial therapy for the relief of symptoms of gastro-oesophageal reflux disease in general practice.
    Venables TL; Newland RD; Patel AC; Hole J; Wilcock C; Turbitt ML
    Scand J Gastroenterol; 1997 Oct; 32(10):965-73. PubMed ID: 9361167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omeprazole or ranitidine for intermittent treatment of GERD?
    Salzberg SA; Newton WP
    J Fam Pract; 1999 May; 48(5):332-3. PubMed ID: 10334603
    [No Abstract]   [Full Text] [Related]  

  • 10. Rabeprazole is equivalent to omeprazole in the treatment of erosive gastro-oesophageal reflux disease. A randomised, double-blind, comparative study of rabeprazole and omeprazole 20 mg in acute treatment of reflux oesophagitis, followed by a maintenance open-label, low-dose therapy with rabeprazole.
    Pace F; Annese V; Prada A; Zambelli A; Casalini S; Nardini P; Bianchi Porro G;
    Dig Liver Dis; 2005 Oct; 37(10):741-50. PubMed ID: 16024305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time to relief of episodic symptoms of gastro-oesophageal reflux disease. A crossover comparison of single doses of the effervescent and standard formulations of ranitidine.
    Elm M; Hellke P; Andrén K; Dahl G; Nyth AL
    Scand J Gastroenterol; 1998 Sep; 33(9):900-4. PubMed ID: 9759942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical trial: the effects of adding ranitidine at night to twice daily omeprazole therapy on nocturnal acid breakthrough and acid reflux in patients with systemic sclerosis--a randomized controlled, cross-over trial.
    Janiak P; Thumshirn M; Menne D; Fox M; Halim S; Fried M; Brühlmann P; Distler O; Schwizer W
    Aliment Pharmacol Ther; 2007 Nov; 26(9):1259-65. PubMed ID: 17944740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Standard-dose lansoprazole is more effective than high-dose ranitidine in achieving endoscopic healing and symptom relief in patients with moderately severe reflux oesophagitis. The Dutch Lansoprazole Study Group.
    Jansen JB; Van Oene JC
    Aliment Pharmacol Ther; 1999 Dec; 13(12):1611-20. PubMed ID: 10594396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cisapride compared with ranitidine in the treatment of functional dyspepsia.
    Carvalhinhos A; Fidalgo P; Freire A; Matos L
    Eur J Gastroenterol Hepatol; 1995 May; 7(5):411-7. PubMed ID: 7614103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are frequent short gastro-oesophageal reflux episodes the cause of symptoms in patients with non-ulcer dyspepsia responding to treatment with ranitidine?
    Farup PG; Hovde O; Breder O
    Scand J Gastroenterol; 1995 Sep; 30(9):829-32. PubMed ID: 8578179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ranitidine in the treatment of symptomatic gastroesophageal reflux disease.
    Sherbaniuk R; Wensel R; Bailey R; Trautman A; Grace M; Kirdeikis P; Jewell L; Pare P; Levesque D; Farley A
    J Clin Gastroenterol; 1984 Feb; 6(1):9-15. PubMed ID: 6321588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-blind crossover study of ranitidine and placebo in gastro-oesophageal reflux disease.
    Johansson KE; Boeryd B; Johansson K; Tibbling L
    Scand J Gastroenterol; 1986 Sep; 21(7):769-78. PubMed ID: 3535004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of omeprazole versus ranitidine for symptomatic treatment of poorly responsive acid reflux disease-a prospective, controlled trial.
    Maton PN; Orlando R; Joelsson B
    Aliment Pharmacol Ther; 1999 Jun; 13(6):819-26. PubMed ID: 10383513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastro-oesophageal reflux disease in The Netherlands. Results of a multicentre pH study.
    Smout AJ; Geus WP; Mulder PG; Stockbrügger RW; Lamers CB
    Scand J Gastroenterol Suppl; 1996; 218():10-5. PubMed ID: 8865445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ranitidine bismuth citrate plus clarithromycin is effective for healing duodenal ulcers, eradicating H. pylori and reducing ulcer recurrence. RBC H. pylori Study Group.
    Peterson WL; Ciociola AA; Sykes DL; McSorley DJ; Webb DD
    Aliment Pharmacol Ther; 1996 Jun; 10(3):251-61. PubMed ID: 8791947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.